-
What’s new in GU Pathology and WHO classification?
November 10, 2022The Uropathology Symposium (ESUP) delivered the latest updates on the WHO classification of genito-urinary tract tumours for 2022, and...
0 -
ESUI22: Examining the near future of imaging
November 10, 2022The 10th Meeting of the EAU Section of Urological Imaging got off to a good start on Thursday, 10 November,...
-
The parallels to mountaineering are everywhere, even in urology
September 27, 2022Vital updates on major trials, emerging technologies, and pioneering techniques will be featured during the 14th European Multidisciplinary Congress...
-
EMUC22 Preview: “Treatment intensification in mHSPC is a hot topic right now”
September 5, 2022The 14th European Multidisciplinary Congress on Urological Cancers (EMUC22) is coming to Budapest, Hungary, from the 10 to 13 November...
-
EMUC22: Relevant topics and Prof. Stenzl’s personal highlights
June 27, 2022Year after year since 2008, the European Multidisciplinary Congress on Urological Cancers (EMUC) provides the urological community with integrative...
-
Recap of EMUC21: The take-home messages
November 30, 2021Being an event with a multidisciplinary nature, the take-home messages of the 13th European Multidisciplinary Congress on Urological Cancers...
-
Another EMUC21 day, another round of best poster award winners
November 28, 2021After three experts from three different fields had won the Best Poster Award – Prostate Cancer on the third...
-
Plenary Session 7 tackles radioimmunotherapy and surgery’s role in immunotherapy era
November 27, 2021Plenary Session 7 “Combining immunotherapy with local treatment of GU cancer” covered topics on radioimmunotherapy for bladder preservation and...
-
Personalised approaches to treating GU cancers
November 27, 2021Personalised approaches such as the use of circulating tumour DNA (ctDNA) biomarkers and genetic testing is the way to...
-
Trial updates: NIMBUS, FLAME and IMvigor130
November 27, 2021Presenters of Plenary Session 5 kickstarted day three of EMUC21 and delivered developments on the trials NIMBUS, Focal Lesion...
News
EMUC24 > News
